A Long-term Access Programme for Subjects With Severe Asthma Who Participated in a GSK-sponsored Mepolizumab Clinical Study

Trial Profile

A Long-term Access Programme for Subjects With Severe Asthma Who Participated in a GSK-sponsored Mepolizumab Clinical Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 19 May 2017

At a glance

  • Drugs Mepolizumab (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Expanded access
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 19 May 2017 This trial was completed in Estonia, according to European Clinical Trials Database.
    • 10 Apr 2017 Status changed from active, no longer recruiting to recruiting.
    • 20 Feb 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top